Linda S. Grais, President and CEO at Ocera Therapeutics, Inc. (OCRX), bought 3,000 shares at $3.19 ($10K) on 2016-03-04, disclosed to the SEC on 2016-03-07.
Open-market purchase of $10k OCRX by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| OCRX | BUY | 2016-01-19 | $21K | — | Filing → |
| OCRX | BUY | 2015-05-06 | $112K | — | Filing → |
| OCRX | BUY | 2014-07-15 | $59K | — | Filing → |